Regenerative Medicine is Awaiting the Mass Production of Therapeutic Adult Tissue Stem Cells that is Possible with Asymmetrex’s SACK Technology and Use of Mouse | Rat | Human Tissue Cells I. SACK Manufacturing of Human Adult Tissue Stem Cells Asymmetrex has a vision of developing SACK manufacturing-scale processes for mass production of human tissue stem
For many years, progress in stem cell medicine has been held back because of a lack of effective and efficient methods for the manufacture of therapeutic adult tissue stem cells. Massachusetts stem cell biotechnology company Asymmetrex announces this week that it now offers a new contract service that can help suppliers of therapeutic adult tissue
Since the beginnings of the field of stem cell biology, more than half a century ago, it has not been possible to count adult tissue stem cells in experimental and clinical preparations. This surprising, but widely known, situation exists because, although tissue stem cells are unique in function from all other tissue cells, they do